US Stock MarketDetailed Quotes
GLPG Galapagos
- 28.450
- -0.320-1.11%
Trading Apr 25 11:22 ET
1.87BMarket Cap8.28P/E (TTM)
28.750High28.350Low81.77KVolume28.750Open28.770Pre Close2.33MTurnover0.18%Turnover Ratio8.28P/E (Static)65.90MShares45.21052wk High0.63P/B1.27BFloat Cap28.35052wk Low--Dividend TTM44.54MShs Float274.030Historical High--Div YieldTTM1.39%Amplitude4.700Historical Low28.490Avg Price1Lot Size
About Galapagos Company
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Company Profile
SymbolGLPG
Company NameGalapagos
Listing DateMay 14, 2015
Issue Price41.52
Founded1999
CEODr. Paulus Stoffels
MarketNASDAQ
Employees1123
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressIndustriepark Mechelen Noord,Generaal de Wittelaan L11 A3
CityMechelen
ProvinceBrussels Region
CountryBelgium
Zip Code2800
Phone32-1-534-29-00
Websitehttp://www.glpg.com
Company Executives
- Name
- Position
- Salary
- Dr. Paulus Stoffels
- Chairman of the Supervisory Board and Chief Executive Officer
- 1.97M
- Thad Allen Huston
- Chief Financial Officer, Chief Operating Officer and Executive Vice President
- --
- Annelies Missotten
- Chief Human Resources Officer and Executive Vice President
- --
- Valeria Cnossen
- General Counsel and Executive Vice President
- --
- Simon John Sturge
- Independent Director
- 28.13K
- Dr. Susanne Schaffert, PhD
- Independent Director
- 60.24K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg